XTLB News and Press, XTL Biopharmaceuticals Ltd. From 03/20/24

2024-03-20 12:25:51 ET More on Mid-day movers & stocks. Personalis, Inc. (PSNL) Q4 2023 Earnings Call Transcript Personalis Q4 2023 Earnings Preview XTI Aircraft that will merge with Inpixon gets Chinese patent for an aircraft Seeking Alpha’s Quant...

expands its IP portfolio to AI Web Data The Social Proxy is a web data AI company developing and powering an IP based platform for AI & BI Applications at scale Secured $1.5 Million in a Private Placement RAMAT GAN, ISRAEL, March 20, 2024 ...

2024-03-20 10:13:02 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Johnson & Johnson, Boston Scientific least shorted stocks in S&...

XTL Biopharmaceuticals Ltd. (XTLB) is expected to report for quarter end 2023-09-30

2023-10-20 16:06:28 ET More on XTL Biopharmaceuticals Financial information for XTL Biopharmaceuticals For further details see: XTL Biopharmaceuticals receives Nasdaq notification regarding minimum bid price deficiency

Ramat Gan, Israel, Oct. 20, 2023 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB, TASE: XTLB.TA) ("XTL" or the "Company"), a clinical stage biopharmaceutical company whose main assets consists of an IP portfolio relating to hCDR1 for the treatment of systemic lupus erythematosus, or...

Ramat Gan, Israel, Oct. 20, 2023 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB, TASE: XTLB.TA) ("XTL" or the "Company"), a clinical stage biopharmaceutical company whose main assets consists of an IP portfolio relating to hCDR1 for the treatment of systemic lupus erythematosus, or...

Super Micro Computer ( SMCI ) +20% on better-than-expected Q4 prelim results. ToughBuilt Industries ( TBLT ) +16% . MoonLake Immunotherapeutics ( MLTX ) +14% . Visionary Education Technology Holdings ( VEDU ) +12% . Olema Pharmaceuti...

Gainers: Triple-S Management (NYSE:GTS) +45%, Bio-Path (NASDAQ:BPTH) +21%, Reviva Pharmaceuticals (NASDAQ:RVPH) +21%, XTL Biopharmaceuticals (NASDAQ:XTLB) +13%, Protara Therapeutics (NASDAQ:TARA) +12%. Losers: Theravance Biopharma (NASDAQ:TBPH) ...

Gainers: Greenpro Capital (NASDAQ:GRNQ) +61%. GeoVax Labs (NASDAQ:GOVX) +49%. Flora Growth Corp. (NASDAQ:FLGC) +31%. Pixelworks (NASDAQ:PXLW) +20%. XTL Biopharmaceuticals (NASDAQ:XTLB) +18%. Leju Holdings (NYSE:LEJU) +17%. Zhihu (NYSE:ZH) +17%. Organovo (NASDAQ:ONVO) +16%. Creatd (NASDAQ:CRTD...